Harvard
Delphia Therapeutics Launches With $67M Series A Financing
The firm is developing a new class of drugs that kill cancer cells by over-activating oncogene pathways.
Biswas Family Foundation, Milken Institute Award $14M in Computational Biology Grants
The funding will support researchers developing artificial intelligence and other computational tools for clinical applications including cancer diagnosis and care.
While the number of ASOs administered to patients with ultra-rare diseases has been steadily increasing, there are still uphill battles for their use.
Bipolar Funding Consortium Aims to Unravel Disorder's Genetics, Reduce Healthcare Disparities
Premium
The ambitious set of projects funded by BD² aims to improve our understanding of bipolar disorder and inform care across the entire spectrum of research and clinical practice.
New Lung Cancer Evolution, Treatment Response Patterns Emerge From TRACERx Study
TRACERx researchers reported on non-small cell lung cancer features linked to disease progression, recurrence, treatment response, and more in seven new papers.